OCT视网膜厚度偏差图用于羟氯喹视网膜病变筛查
本研究基于1192例韩国羟氯喹治疗患者,开发并验证基于扫频源OCT视网膜厚度偏差图的诊断标准。结果显示,双眼出现至少5个连续红色像素且符合5种特征模式之一时,在发现集和验证集中敏感度分别为98.2%和100%,特异度分别为89.1%和87.5%。异常像素面积与Humphrey 30-2视野的平均偏差和模式标准差显著相关(P < 0.001)。
要点
- 视网膜厚度偏差图可客观评估羟氯喹视网膜病变,无需主观判断外层视网膜形态。
- 诊断标准:双眼至少5个连续红色像素且符合5种特征模式之一。
- 异常像素面积与视野平均偏差和模式标准差显著相关(P < 0.001)。
核心结论
- 视网膜厚度偏差图有助于客观评估羟氯喹视网膜病变,可与常规筛查方法联合使用以提高筛查效果。
研究设计与样本
- 回顾性队列研究,纳入1192例有羟氯喹治疗史的韩国患者,发现集881例(1723眼),验证集311例(591眼)。
- 根据2016年美国眼科学会指南,结合SS OCT、眼底自发荧光和标准自动视野计筛查视网膜毒性。
- 使用12×9 mm²黄斑体积SS OCT扫描,自动生成视网膜厚度偏差图,黄色像素(厚度<5%正常水平)或红色像素(<1%正常水平)定义为异常。
主要发现
- 羟氯喹视网膜病变眼的异常模式包括:环中心型(36.0%)、环旁中心型(6.1%)、混合环型(34.2%)、中心岛型(13.2%)和全黄斑变薄(10.5%)。
- 诊断标准(双眼至少5个连续红色像素且符合5种特征模式之一)在发现集中敏感度98.2%、特异度89.1%,在验证集中敏感度100%、特异度87.5%。
- 异常像素面积与Humphrey 30-2视野的平均偏差(P < 0.001)和模式标准差(P < 0.001)显著相关。
关键数值与推荐
- 视网膜厚度偏差图中,黄色像素定义为视网膜厚度<5%正常水平,红色像素定义为<1%正常水平。
- 诊断标准:双眼至少5个连续红色像素且符合5种特征模式之一。
- 发现集敏感度98.2%、特异度89.1%;验证集敏感度100%、特异度87.5%。
临床怎么用
- 可将视网膜厚度偏差图作为羟氯喹视网膜病变筛查的客观辅助工具,与常规筛查方法联合使用。
- 判读时关注双眼至少5个连续红色像素及5种特征模式(环中心型、环旁中心型、混合环型、中心岛型、全黄斑变薄)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the use of a retinal thickness deviation map generated from swept-source (SS) OCT images for hydroxychloroquine retinopathy screening. DESIGN: Retrospective cohort study. PARTICIPANTS: This study included 1192 Korean patients with a history of hydroxychloroquine treatment: 881 patients (1723 eyes) in the discovery set and 311 patients (591 eyes) in the validation set. Patients were screened for retinal toxicity using SS OCT, fundus autofluorescence, and standard automated perimetry. METHODS: According to the 2016 American Academy of Ophthalmology guidelines, hydroxychloroquine retinopathy was diagnosed by the presence of abnormalities on ≥1 objective structural tests alongside corresponding visual field defects. The 12 × 9-mm2 macular volume SS OCT scan was performed, and the retinal thickness deviation map was generated automatically using the built-in software. On this map, yellow (retinal thickness, <5% of the normative level) or red (<1% of the normative level) pixels were defined as abnormal. Abnormal findings were evaluated, and diagnostic criteria were developed based on the discovery set data; criteria were validated using the validation set data. MAIN OUTCOME MEASURES: The rate and patterns of abnormalities on the retinal thickness deviation map and sensitivity and specificity of the diagnostic criteria. RESULTS: The retinal thickness deviation map showed the following abnormal patterns in eyes with hydroxychloroquine retinopathy: pericentral (36.0%) or parafoveal (6.1%) ring, mixed-ring (34.2%), central island (13.2%), and whole macular thinning (10.5%). The criterion of ≥5 contiguous red pixels showing 1 of the 5 characteristic patterns in both eyes yielded the greatest diagnostic performance (sensitivity and specificity of 98.2% and 89.1% and of 100% and 87.5% in the discovery and validation set data, respectively). Moreover, the area of abnormal pixels on the map was correlated significantly with the mean deviation (P < 0.001) and pattern standard deviation (P < 0.001) on the Humphrey 30-2 test in eyes with hydroxychloroquine retinopathy. CONCLUSIONS: The retinal thickness deviation map may facilitate the objective evaluation of hydroxychloroquine retinopathy because it does not require subjective, morphologic evaluation of the outer retinal layers. The map has the potential to enhance hydroxychloroquine retinopathy screening when used in conjunction with conventional screening methods.
引用
- Kim KE, Ahn SJ, Woo SJ, et al. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening. Ophthalmology. 2020. PMID: 32553941. doi:10.1016/j.ophtha.2020.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。